CompletedPhase 3NCT00004778

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Antenatal Thyrotropin-Releasing Hormone in Pregnant Women With Threatened Premature Delivery

Studying Infant acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Center for Research Resources (NCRR)
Principal Investigator
Roberta A. Ballard
Children's Hospital of Philadelphia
Intervention
betamethasone(drug)
Enrollment
1090 enrolled
Eligibility
0 years · FEMALE
Timeline
1993

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Children's Hospital of Philadelphia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004778 on ClinicalTrials.gov

Other trials for Infant acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Infant acute respiratory distress syndrome

← Back to all trials